Literature DB >> 35357828

Isolation, Identification, and Immunomodulatory Mechanism of Peptides from Lepidium meyenii (Maca) Protein Hydrolysate.

Ping He1, Leiman Pan1, Hui Wu1, Lina Zhang1, Yi Zhang1, Yizhe Zhang1, Jinxi Yang1, Zhengli Lin1, Mengmeng Zhang1.   

Abstract

Maca is a protein-enriched edible plant with immunomodulatory activity. However, the role of proteins in the immunomodulatory activity of maca is unclear. In this study, peptide products of maca proteins obtained through in vitro gastrointestinal digestion were isolated and purified, and the immunomodulatory activities of these peptides were assessed in macrophages (RAW 264.7 cells). The results show that the maca protein hydrolysate enhanced the phagocytic capacity and NO, TNF-α, and IL-6 secretion of RAW 264.7 cells. Forty-five peptides from known proteins of maca or the cruciferous family were identified by ultraperformance liquid chromatography-tandem mass spectrometry in the hydrolysate, and the peptide RNPFLP exhibited the strongest immunomodulatory activity. Antibody blocking, siRNA, pathway inhibitors, and western blot assays showed that RNPFLP-activated RAW 264.7 cells through the NF-κB and MAPK signaling pathways mediated by TLR2 and TLR4 receptors. An analysis of the structure-activity relationship showed that the N9-H60 active site in arginine plays an important role in the immunomodulatory activity of RNPFLP. This study provides a new understanding of the immunomodulatory activity of maca.

Entities:  

Keywords:  gastrointestinal digestion; macrophage; signaling pathway; structure−activity relationship; toll-like receptors

Mesh:

Substances:

Year:  2022        PMID: 35357828     DOI: 10.1021/acs.jafc.1c08315

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  1 in total

1.  Immunoenhancing Effects of Cyclina sinensis Pentadecapeptide through Modulation of Signaling Pathways in Mice with Cyclophosphamide-Induced Immunosuppression.

Authors:  Rui Zhao; Xiao-Xia Jiang; Qiao-Ling Zhao; Han-Wei Ye; Yi Lin; Ju Huang; Yun-Ping Tang
Journal:  Mar Drugs       Date:  2022-08-31       Impact factor: 6.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.